5Brunstrom JE,Bastian AJ,Wong M,et al. Motor benefit from levodopa in spastic quadriplegic cerebral palsy[ J ]. Ann Neurol, 2000,47 (2) :662～665 被引量：1
6Bakheit AM,Severa S, Cosgrovc A, et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscles spasticity[J ].Dev Med Child Neurol,2001,43(4) :234～238 被引量：1
7Gage JR. Gait analysis in cerebral palsy[M]. London: Mackeith Press, 1991:124 被引量：1
8Russman BS, Tilton A, Gormley ME Jr. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in trestment[J ]. Muscle Nerve Suppl, 1997,6: S181 ～ 193 被引量：1
9Yablon SA. Botulinum neurotoxin intramuscular chemodenervation.Role in the management of spastic hypertonia and related motor disorders[J]. Phys Med Rehabil Clin N Am,2001,12(4) :833～874 被引量：1
10Corry IS, Cosgrove AP, Walsh EG, et al. Botulinum toxin A in the hemiplegic upper limb: a double-bling trial[J ]. Dev Med Child Neurol, 1997,39(3): 185～ 193 被引量：1
